Important Drug-Drug Interactions Involving INR and Warfarin Flashcards
Amiodarone {when taken with Warfarin} causes INR to (increase/decrease).
Increase (based on CYP inhibition of 2C9 (metabolizes S-enantiomer of warfarin) in addition to potentially promoting a hyperthyroid state which leads to clotting factor breakdown)
Androgens [Danazol, Methyltestosterone, Oxandrolone] {when taken with Warfarin} cause INR to (increase/decrease).
Increase (appears to cause increase in AUC of vitamin K antagonists)
Antibiotics {when taken with Warfarin} can cause INR to (increase/decrease).
Increase (based on CYP inhibition, alterations to vitamin K2 flora, as well as possible protein binding alterations) [POTENTIALLY STRONG INTERACTION]
Azole antifungals (fluconazole, itraconazole) {when taken with Warfarin} cause INR to (increase/decrease).
Increase due to CYP2C9/3A4 inhibition [STRONG INTERACTION]
Which antibiotics are commonly implicated in increasing INR {when taken with Warfarin}?
Sulfonamide antibiotics like Bactrim (due to CYP2C9 inhibition, protein displacement, GI flora alterations), metronidazole (CYP2C9 inhibition), doxycycline (potentially due to PT reductions or flora changes), macrolides (based on GI flora changes), cephalosporins (anticoagulant properties based on side chain properties, platelet inhibition and K2 GI flora killing)
Cancer therapies (Capecitabine, Imatinib, Tamoxifen, 5-FU) {when taken with Warfarin} can cause INR to (increase/decrease).
Increase, however limited data exists for the Imatinib-Warfarin interaction; Capecitabine, 5-FU and Tamoxifen (to a lesser extent) all inhibit CYP2C9 and can greatly raise the AUC of Warfarin
Acetaminophen {when taken with Warfarin} causes INR to (increase/decrease).
Increase (at doses GREATER than 2,000 mg/day; may be due to ingestion of APAP leading to reduction in the concentration of vitamin K-dependent clotting factors)
Fenofibrate and Gemfibrozil {when taken with Warfarin} cause INR to (increase/decrease).
Increase (via CYP2C9 inhibition, increased anticoagulant affinity for binding sites and potential protein displacement)
Statins (Rosuvastatin, Fluvastatin) {when taken with Warfarin} cause INR to (increase/decrease).
Increase (from studies that demonstrate raised AUC/Cmax with concomitant administration; may be due to CYP2C9 inhibition)
Steroids {when taken with Warfarin} cause INR to (increase/decrease).
Increase (via enhanced anticoagulation effect by an unclear mechanism).
SSRIs [Fluoxetine, Duloxetine] and some SNRIs (Venlafaxine) {when taken with Warfarin} can cause INR to (increase/decrease).
Increase (due to some antidepressants having antiplatelet properties that result in bleeding risk).
Levothyroxine {when taken with Warfarin} can cause INR to (increase/decrease).
Increase (enhanced via several pathways: hypothyroidism may be associated with slowed vitamin K dependent clotting factor metabolism, warfarin protein binding reduction, increased affinity for vitamin K-dependent epoxide reductase with warfarin)
Phenytoin and Warfarin interaction
Phenytoin may raise warfarin response by displacing warfarin from binding sites (transiently), but this boost in response may be undone by induction of CYP3A4 and 1A2 (which partially metabolizes warfarin). This interaction may also cause increased phenytoin exposure.
Tramadol {when taken with Warfarin} can cause INR to (increase/decrease).
Increase (via enhanced anticoagulant effects through potential CYP3A4-mediated metabolism competition).
Dicloxacillin {when taken with Warfarin} can cause INR to (increase/decrease).
Decrease (via diminished anticoagulant effect by inducing CYP3A4 and 2C9).